Philipp Nold

Philipp Nold is a Business Development Manager for Cell and Gene Therapy at Eppendorf Group, a position held since 2023, where leadership in strategic expansion across Europe has been pivotal for growth in this segment. Prior roles within Eppendorf include Bioprocess Sales Specialist from 2019 to 2023, focusing on small-, bench-, and pilot-scale bioprocess solutions, and Infield Application Specialist from 2017 to 2019, specializing in stem cell culture and bioprocess applications. Nold's earlier experience includes research at Universitätsklinikum Gießen und Marburg GmbH, focusing on the GMP-compliant expansion and characterization of human mesenchymal stromal cells. Educationally, Nold holds a Diplom in Biological Sciences from Ruhr University Bochum and a Vordiplom from RPTU Kaiserslautern-Landau, alongside early studies at Karlsruhe Institute of Technology.